[89Zr]Zr-DFO-BIIB080

N/A

Report date: 2025/11/21 17:16:30

Base Information

Drug Name[89Zr]Zr-DFO-BIIB080

Drug Alias Name[89Zr]Zr-DFO-ISIS-814907[89Zr]Zr-DFO

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisenseRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Zirconium > 89Zr +[4]

Mechanisms of ActionMicrotubule-associated protein tau inhibitors

TargetsMicrotubule-associated protein tau

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesBiogen Inc

China Registration ClassN/A

Develop Information

Active CompaniesBiogen Inc

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A